Program
General information:
The conference language is English.
Friday, 20.11.15
09:00 |
Registration, welcome reception with coffee
|
10:00 |
Opening
|
10:05 |
General session
|
| 10:05 | GERAMY, a German interdisciplinary network for AL amyloidosis |
| S. Schönland | |
| 10:20 | Advances and unmet needs in systemic amyloidosis |
| G. Merlini | |
| 10:50 | A new approach in systemic amyloidosis: immunotherapeutic removal of amyloid |
| Sir M. Pepys | |
| 11:20 | Molecular basis of amyloid fibril formation |
| C. Dobson | |
12:00 |
Lunch |
12:45 |
Clinical features, genetics and diagnostics in AL
|
| 12:45 | GERAMY SP 3 – Amyloid Registry Kiel – advancing diagnostics of amyloidoses in surgical pathology |
| C. Röcken | |
| 13:05 | GERAMY SP 2 – Recurrent copy number aberrations in 100 AL amyloidosis patients |
| M. Granzow | |
| 13:20 | Mechanisms and toxicity of Light chain misfolding and amyloid formation |
| M. Ramirez-Alvarado | |
14:00 |
The five best abstracts
|
15:00 |
Poster session within Coffee break
|
16:00 |
Basic science in AL
|
| 16:00 | GERAMY SP 2 – Amyloid Light Chain Sequence Detection and Evaluation |
| R. Köhler | |
| 16:15 | GERAMY SP 4 – Analysis of the fibril structure with electron microscopy |
| M. Fändrich | |
| 16:35 | GERAMY SP 5 – NMR spectroscopic investigations of amyloid aggregates |
| B. Reif | |
| 16:55 | Not created equal: effect of point mutations on amyloid formation of VL |
| J. Buchner | |
| 17:15 | GERAMY SP 6 – EGCG modulated aggregation of patient derived light chain amyloid |
| J. Bieschke | |
| 17:35 | GERAMY SP 7 – Targeting of pathogenic light chain aggregates from patients with small molecules |
| E. Wanker | |
17:55 |
End of last session |
19:30 |
DinnerRestaurant at the NH-Hotel |
Saturday, 21.11.15
08:30 |
Registration |
09:00 |
Therapy in systemic amyloidosis
|
| 09:00 | Mechanisms of TTR amyloidosis misfolding, drug development and treatment |
| J. Kelly | |
| 09:30 | Results of liver transplantation and current studies on gene therapy in TTR amyloidosis |
| O. Suhr | |
| 10:00 | Novel Approaches to Patients with AL a myloidosis |
| R. Comenzo | |
| 10:30 | Current strategies of stem cell transplantation in AL amyloidosis |
| V. Sanchorawala | |
11:00 |
Coffee |
11:30 |
Biology, clinics and fibril formation in localized and systemic amyloidosis
|
| 11:30 | Localized AL amyloidosis |
| P. Westermark | |
| 12:00 | Imaging in local and systemic amyloidosis |
| B. Hazenberg | |
| 12:20 | Nanoparticles and Nanobodies: Interaction with Amyloidogenic Proteins |
| G. Esposito | |
| 12:40 | IAPP in Alzheimers Disease |
| G. Westermark | |
| 13:00 | Clinical characteristics of AA-Amyloidosis in Germany |
| N. Blank | |
13:15 |
Lunch |
14:00 |
Biology, clinics and prognosis in AL amyloidosis
|
| 14:00 | GERAMY SP 1 – EGCG treatment in AL amyloidosis |
| U. Hegenbart | |
| 14:15 | EGCG treatment in ATTR amyloidosis |
| A. Kristen | |
| 14:30 | Echocardiography in AL and ATTR amyloidosis |
| D. Mereles | |
| 14:45 | MRI of peripheral nerves in AL and ATTR amyloidosis |
| J. Kollmer | |
| 15:00 | Immuno-Phenotype of the plasma cell clone in AL amyloidosis |
| K. Lisenko | |
| 15:15 | Results of iFISH in AL amyloidosis |
| T. Bochtler | |
| 15:30 | Plasma cell genetics in multiple myeloma and AL amyloidosis |
| D. Hose | |
| 15:45 | Results of GWAS in multiple myeloma and AL amyloidosis |
| S. Huhn | |
16:00 |
Conclusion |
16:00 |
End of the Congress / coffee |
